Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

8.52
Delayed Data
As of Jul 31
 +0.13 / +1.55%
Today’s Change
6.76
Today|||52-Week Range
16.87
-30.45%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization121.0K121.0K136.0K160.0K
 
 
 
 
 
 
Operating ExpensesGross Income-121.0K-121.0K-136.0K-160.0K
 
 
 
 
 
General Expenses15.7M15.9M21.5M19.3M
 
 
 
 
 
Research And Development12.3M12.3M16.4M15.2M
 
 
 
 
 
Total Operating Expenses15.8M16.0M21.7M19.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.8M-16.0M-21.7M-19.5M
 
 
 
 
 
Interest Expense On Debt8.0K4.0K13.0K16.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.7M-15.9M-21.6M-19.3M
 
 
 
 
 
Income Taxes0.00-260.0K0.00-70.0K
 
 
 
Net Income-15.7M-15.7M-21.6M-19.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS97.0M99.0M100.6M111.2M
 
 
 
 
 
Shares To Calculate EPS Diluted97.0M99.0M100.6M111.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16-$0.16-$0.21-$0.17
 
 
 
 
 
EPS Diluted-$0.16-$0.16-$0.21-$0.17